Pesquisas alternativas:
doses devel » doses seven (Expandir a Pesquisa), doses derived (Expandir a Pesquisa), doses devoid (Expandir a Pesquisa)
does novel » does nose (Expandir a Pesquisa)
novel ther » novel ether (Expandir a Pesquisa), novel thr (Expandir a Pesquisa), novel theory (Expandir a Pesquisa)
dose level » dose levels (Expandir a Pesquisa), noise level (Expandir a Pesquisa), dose live (Expandir a Pesquisa)
drug does » drug doses (Expandir a Pesquisa), drugs does (Expandir a Pesquisa), drug dose (Expandir a Pesquisa)
doses devel » doses seven (Expandir a Pesquisa), doses derived (Expandir a Pesquisa), doses devoid (Expandir a Pesquisa)
does novel » does nose (Expandir a Pesquisa)
novel ther » novel ether (Expandir a Pesquisa), novel thr (Expandir a Pesquisa), novel theory (Expandir a Pesquisa)
dose level » dose levels (Expandir a Pesquisa), noise level (Expandir a Pesquisa), dose live (Expandir a Pesquisa)
drug does » drug doses (Expandir a Pesquisa), drugs does (Expandir a Pesquisa), drug dose (Expandir a Pesquisa)
41
Por Klymenko, Tetyana, Brandenburg, Martin, Morrow, Christopher, Dive, Caroline, Makin, Guy
Publicado em 2011
“..., and leads to pleiotropic drug resistance, mediated by Bcl-2 family proteins. ABT-737 is a novel small...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
42
Por Lee, Jieon, Yoon, Seonghae, Shin, Donghoon, Han, HyeKyung, An, Hyungmi, Lee, Jongtae, Lim, Kyoung Soo, Yu, Kyung-Sang, Lee, Howard
Publicado em 2014
“... nomograms may be required in patients with IE, particularly for once-daily dosing. Therapeutic drug...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
43
“...-analysis to assess the effect of preoperative loading dose ticagrelor and clopidogrel on no-reflow (NRF...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
44
Por Takeuchi, Tsutomu, Miyasaka, Nobuyuki, Inui, Takashi, Yano, Toshiro, Yoshinari, Toru, Abe, Tohru, Koike, Takao
Publicado no Arthritis Res Ther (2017)
“... TNF level, serum infliximab level, and disease activity were compared between the three classes...”Publicado no Arthritis Res Ther (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
45
Por Kim, Yo Han, Choi, Hee Youn, Noh, Yook-Hwan, Lee, Shi Hyang, Lim, Hyeong-Seok, Kim, Chin, Bae, Kyun-Seop
Publicado no Drug Des Devel Ther (2015)
“... and high blood pressure. The aim of this study was to investigate the dose proportionality...”Publicado no Drug Des Devel Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
46
Por Safouris, Apostolos, Triantafyllou, Nikos, Parissis, John, Tsivgoulis, Georgios
Publicado no Ther Adv Neurol Disord (2015)
“... fibrillation as a convenient therapy that needs no drug level monitoring. However, analysis of the data...”Publicado no Ther Adv Neurol Disord (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
47
“... was to assess plasma levels, tissue distribution, and excretion of total radioactivity (TR) after single-dose...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
48
Por Erturk, Ayse, Adnan Akdogan, Remzi, Parlak, Emine, Cure, Erkan, Cumhur Cure, Medine, Ozturk, Cinar
Publicado em 2014
“... transaminase (ALT) normalization at the end of 4 years. CONCLUSION: Increasing ETV dose from 0.5 mg to 1 mg...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
49
Por Min, Jee Sun, Kim, Doyun, Park, Jung Bae, Heo, Hyunjin, Bae, Soo Hyeon, Seo, Jae Hong, Oh, Euichaul, Bae, Soo Kyung
Publicado no Drug Des Devel Ther (2016)
“...BACKGROUND: Evaluating the potential risk of metabolic drug–drug interactions (DDIs) is clinically...”Publicado no Drug Des Devel Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
50
“... as toxicology of ambroxol. It has been concluded that even at the highest clinically used doses ambroxol does...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
51
“.... Nonsteroidal anti-inflammatory drugs (NSAIDs) play an essential role associated with their analgesic potency...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
52
Por Lee, Sook Joung, Park, Min Kyu, Shin, Dong-Seong, Chun, Min Ho
Publicado no Drug Des Devel Ther (2017)
“... drugs (NSAIDs). We investigated the inhibitory effects on COX-2 after NSAIDs administration using a...”Publicado no Drug Des Devel Ther (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
53
Por Zhi, Li-Juan, Wang, Li, Chen, Xing-Kai, Zhai, Xiao-Ying, Wen, Li, Dong, Lei, Jacqz-Aigrain, Evelyne, Shi, Zhong-Ren, Zhao, Wei
Publicado no Drug Des Devel Ther (2018)
“... and Drug Administration for the treatment of infections caused by susceptible bacteria in both adults...”Publicado no Drug Des Devel Ther (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
54
“... years and 65 years and older, and between those treated with a low and a high dose of each drug...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
55
Por Vandendriessche, Anaïs, Allegaert, Karel, Cossey, Veerle, Naulaers, Gunnar, Saegeman, Veroniek, Smits, Anne
Publicado em 2014
“... trough levels achieved using 2 published dosing regimens (previous regimen: based on postmenstrual age...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
56
“... examined the impact of altering the insulin dose administered on hypoglycemia development; no trials...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
57
Por Stelzer, Daniela, Weber, Alexandra, Ihle, Franziska, Matthes, Sandhya, Ceelen, Felix, Zimmermann, Gregor, Kneidinger, Nikolaus, Schramm, Rene, Winter, Hauke, Zoller, Michael, Vogeser, Michael, Behr, Juergen, Neurohr, Claus
Publicado no Ther Drug Monit (2017)
“...BACKGROUND: This study compared therapeutic azole plasma trough levels (APL) of the azole...”Publicado no Ther Drug Monit (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
58
Por Ong, Cheung-Ter, Wong, Yi-Sin, Wu, Chi-Shun, Su, Yu-Hsiang
Publicado no Drug Des Devel Ther (2017)
“...BACKGROUND AND PURPOSE: Intravenous recombinant tissue plasminogen activator (tPA) at a dose of 0.9...”Publicado no Drug Des Devel Ther (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
59
Por Park, Jin-Sun, Shin, Joon-Han, Hong, Taek-Jong, Seo, Hong-Seog, Shim, Wan-Joo, Baek, Sang-Hong, Jeong, Jin-Ok, Ahn, Youngkeun, Kang, Woong-Chol, Kim, Young-Hak, Kim, Sang-Hyun, Hyon, Min-Su, Choi, Dong-Hoon, Nam, Chang-Wook, Park, Tae-Ho, Lee, Sang-Chol, Kim, Hyo-Soo
Publicado no Drug Des Devel Ther (2016)
“... compliance. This study aimed to evaluate the efficacy and safety of fixed-dose combination (FDC) therapy...”Publicado no Drug Des Devel Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
60
“...Paclitaxel (Taxol), one of the most important anticancer drugs, has been used for therapy...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo